Table 4.
Author | Year | Cases | Prognostic factors | Median survival time | 5-yr survival rate | Routine LND |
Ribero et al[8] | 2012 | 434 | LN metastases | 33 | 32.90% | No |
Multiple tumors | ||||||
CA19.9 level | ||||||
de Jong et al[9] | 2011 | 449 | Tumor number | 27.3 | 30.7 | No |
Vascular invasion | ||||||
LN metastasis | ||||||
Saxena et al[26] | 2010 | 88 | CA 19.9 level | 33 | 28 | No |
Clinical stage | ||||||
Histological grade | ||||||
LN metastases | ||||||
Ercolani et al[27] | 2010 | 72 | LN metastasis | 57.1 | 48 | Yes |
Blood transfusion | ||||||
Cho et al[28] | 2010 | 63 | Old age | Not available | 31.8 | Yes |
CA19-9 level | ||||||
LN metastasis | ||||||
Narrow resection margin | ||||||
Shirabe et al[29] | 2010 | 60 | Lymphatic invasion index | Not available | 30.6 | No |
Histological grade | ||||||
Guglielmi et al[30] | 2009 | 81 | LN metastasis | 40 | 20 | Not available |
Vascular invasion | ||||||
Tamandl et al[31] | 2009 | 93 | Lymph node ratio | 25.5 | Not available | No |
Choi et al[37] | 2009 | 64 | LN metastasis | 39 | 39.5 | No |
Shimada et al[32] | 2009 | 104 | Intrahepatic metastases | 25 | 37 | No |
LN metastasis | ||||||
Yedibela et al[33] | 2009 | 67 | Resection margin | 26 | 27 | No |
LN metastasis | ||||||
Blood transfusion | ||||||
Nakagohri et al[34] | 2008 | 56 | Intrahepatic metastasis | 22 | 32 | Not available |
Uenishi et al[35] | 2008 | 133 | Intrahepatic metastasis | 18.4 | 29 | Yes |
LN metastases | ||||||
Tumor at the margin | ||||||
Shimada et al[36] | 2007 | 57 | LN metastasis | 62 | 56.8 | No |
LN: Lymph node; LND: Lymph node dissection; ICC: Intrahepatic cholangiocarcinoma.